Amoéba
Develops natural microbiological solutions to manage bacterial and fungal risks.
ALMIB | PA
Overview
Corporate Details
- ISIN(s):
- FR0011051598 (+2 more)
- LEI:
- 9695005QNE7C8Z0LXU64
- Country:
- France
- Address:
- 38 AVENUE DES FRERES MONTGOLFIER, 69680 CHASSIEU
- Website:
- https://amoeba-nature.com/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of other chemical products
Description
Amoéba is a biotechnology company that develops natural microbiological solutions for managing bacterial and fungal risks. The company's core technology is based on the patented use of the amoeba *Willaertia magna* C2c Maky and its biocidal properties. Its primary focus is on agricultural biocontrol, offering a biofungicide derived from a mechanically lysed amoeba. This product targets plant diseases such as mildews, rusts, and powdery mildew, providing a biological alternative to chemical treatments. Amoéba has also developed applications for its technology in the treatment of bacterial risk in industrial water systems, on surfaces, and for chronic wounds.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2021-03-04 17:45 |
AMOEBA announces the issuance of the twelfth tranche of 26 bonds convertible in…
|
English | PDF • 285.6 KB | ||
| 2021-03-03 17:45 |
AMOEBA : Déclaration du nombre total de droits de vote et du nombre d’actions c…
|
French | PDF • 231.6 KB | ||
| 2021-02-04 17:45 |
AMOEBA annonce l’émission de la onzième tranche de 26 obligations convertibles …
|
French | PDF • 364.6 KB | ||
| 2021-02-04 17:45 |
AMOEBA announces the issuance of the eleventh tranche of 26 bonds convertible i…
|
English | PDF • 302.2 KB | ||
| 2021-02-03 17:45 |
AMOEBA : Déclaration du nombre total de droits de vote et du nombre d’actions c…
|
French | PDF • 231.0 KB | ||
| 2021-01-11 17:45 |
AMOEBA CONFIRME SON ELIGIBILITE AU DISPOSITIF PEA-PME
|
French | PDF • 192.1 KB | ||
| 2021-01-07 17:45 |
AMOEBA : BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE
|
French | PDF • 406.1 KB | ||
| 2021-01-06 17:45 |
AMOEBA annonce l’émission de la dixième tranche de 26 obligations convertibles …
|
French | PDF • 372.1 KB | ||
| 2021-01-06 17:45 |
AMOEBA announces the issuance of the tenth tranche of 26 bonds convertible into…
|
English | PDF • 312.5 KB | ||
| 2021-01-05 17:45 |
AMOEBA : Déclaration du nombre total de droits de vote et du nombre d’actions c…
|
French | PDF • 242.9 KB | ||
| 2020-12-21 17:45 |
AMOEBA RENOUVELLE UNE LIGNE DE FINANCEMENT D’AU MAXIMUM 23 M€ AVEC NICE & G…
|
French | PDF • 431.5 KB | ||
| 2020-12-21 17:45 |
AMOEBA RENEWS A FINANCING LINE OF UP TO €23M WITH NICE & GREEN TO SUPPORT I…
|
English | PDF • 270.9 KB | ||
| 2020-12-18 08:30 |
AMOEBA SIGNE UN ACCORD DE DEVELOPPEMENT ET DE COMMERCIALISATION NON EXCLUSIF EN…
|
French | PDF • 271.2 KB | ||
| 2020-12-18 08:30 |
AMOEBA SIGNS A NON-EXCLUSIVE DEVELOPMENT AND MARKETING AGREEMENT IN SWITZERLAND…
|
English | PDF • 229.9 KB | ||
| 2020-12-17 17:45 |
AMOEBA ANNONCE LA NOMINATION DE PIERRE MORGON EN QUALITE DE CENSEUR AU CONSEIL …
|
French | PDF • 262.7 KB |
Automate Your Workflow. Get a real-time feed of all Amoéba filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Amoéba
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Amoéba via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-08-30 | N/A | Other | Buy | 6,300 | 3,609.90 EUR |
| 2024-08-29 | N/A | Other | Sell | 5,500 | 3,564.00 EUR |
| 2024-08-28 | N/A | Other | Buy | 3,200 | 1,782.08 EUR |
| 2024-08-27 | N/A | Other | Buy | 20,049 | 11,231.45 EUR |
| 2024-08-26 | N/A | Other | Buy | 31,107 | 17,441.69 EUR |
| 2024-08-22 | N/A | Other | Buy | 2,255 | 1,298.88 EUR |
| 2024-08-20 | N/A | Other | Buy | 16,664 | 8,838.59 EUR |
| 2024-08-19 | N/A | Other | Buy | 13,390 | 6,795.43 EUR |
| 2024-08-16 | N/A | Other | Buy | 6,745 | 3,468.28 EUR |
| 2024-08-09 | N/A | Other | Buy | 40,748 | 21,559.77 EUR |
Peer Companies
